Evaluation of the Safety of Terahertz Scanning System on Corneas
ConditionCorneal Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age21+
SponsorSingapore Eye Research Institute
About this trial
This observational study aims to establish the safety profile of the use of Terahertz (THz) scanning system on corneal diseases. Participants with "non-seeing" eyes but normal corneas will undergo THz scanning. Eye examinations will be conducted at baseline, immediately after scanning, and at 1 day, 1 week, and 1 month post-scanning. These examinations will include measurements of visual acuity, eye structural, retinal health, corneal cell morphology, and corneal nerve status. The investigators hypothesize that the THz scanning system is safe for application to the human cornea.
Eligibility criteria
Qualifiers
Be at least 21 years of age
Regardless of gender (Male/Female)
Regardless of race (Chinese/Malay/Indian/Eurasian/Others)
Willingness and ability to follow all instructions and comply with study schedule for study visit
Disqualifiers
Pregnant/Breast-feeding women
Eyes with previous major surgery on the cornea such as corneal transplantation, refractive surgery, corneal cross-linking procedure
Eyes with previous infectious keratitis
Eyes with long-term use of glaucoma eye drops
Trial design
Treatments tested in this trial
- Terahertz (THz) scanning using THz Imaging system.
Treatment groups
5 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov